The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2023 | Developments in assessing frailty in patients with multiple myeloma
In this video, Gordon Cook, MB ChB, PhD, FRCP(Glas), FRCPath, Leeds Teaching Hospitals NHS Trust, Leeds, UK, discusses the categorization of patients with multiple myeloma as fit, unfit, or frail using the International Myeloma Working Group (IMWG) frailty index. Prof. Cook explains how treatment can be tailored based on these categories, but also highlights the limitations of these types of assessments. Prof. Cook also discusses a sub-study of the Myeloma XIV (FiTNEss) trial (NCT03720041) that is using trackers to measure patients’ physical activity to improve delineation of patient fitness, and concludes by discussing the dynamic nature of patient frailty. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
